4-Methylephedrine

4-Methylephedrine
Clinical data
Pronunciation/ˌfɔːr mɛθəlɪˈfɛdrɪn/
Other names4-ME; Dihydromephedrone; DHMMC; β-Hydroxy-4-methylmethamphetamine; 4-Methyl-β-hydroxymethamphetamine
Drug classStimulant; Monoamine releasing agent
ATC code
  • None
Legal status
Legal status
  • Generally not controlled
Identifiers
  • 2-(methylamino)-1-(4-methylphenyl)propan-1-ol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H17NO
Molar mass179.263 g·mol−1
3D model (JSmol)
Density0.987 to 1.00 g/cm3
Melting point56.1 to 89.0 °C (133.0 to 192.2 °F)
Boiling point269 to 281 °C (516 to 538 °F)
Solubility in water1.61e-2 to 0.110 (water) mg/mL (20 °C)
  • CC1=CC=C(C=C1)C(C(C)NC)O
  • InChI=1S/C11H17NO/c1-8-4-6-10(7-5-8)11(13)9(2)12-3/h4-7,9,11-13H,1-3H3
  • Key:DUESQFQLBNOCIT-UHFFFAOYSA-N

4-Methylephedrine (4-ME), also known as dihydromephedrone (DHMMC) or as β-hydroxy-4-methylmethamphetamine, is a putative stimulant drug of the phenethylamine, amphetamine, and β-hydroxyamphetamine families. It is the β-hydroxy analogue of mephedrone and is a known metabolite of mephedrone. The drug acts as a monoamine reuptake inhibitor and monoamine releasing agent, albeit with relatively low potency and far less than that of mephedrone.